Bisneto, J. V., Merryman, R., Smith, S., Wallace, D., Marolleau, J. P., Arcaini, L., Grande, C., Albareda, F. B., Pinto, A., Gutierrez, N., Till, B., Mora, M. R. F., Morel, P., Rattotti, S., Herce, C. G., Rinaudo, P., Carpier, J., Fagerberg, J., Zinzani, P. L., Friedberg, J., Armand, P., Ansell, S. (2025). EO2463 (EO) peptide immunotherapy in patients (pts) with newly diagnosed asymptomatic follicular lymphoma (FL) and marginal zone lymphoma (MZL): Study EONHL1-20/sidney (NCT04669171) primary endpoint lugano objective response analysis. Blood. https://doi.org/10.1182/blood-2025-5377